8-K: Align Technology Reports Solid Q2 2024 Results, Driven by Clear Aligner and Imaging Systems Growth

Align Technology's Q2 2024 results show a 2.6% year-over-year revenue increase to $1,028.5 million, with growth in both clear aligner volumes and imaging systems.

Summary

• Align Technology announced its second quarter 2024 financial results, with total revenues reaching $1,028.5 million, a 3.1% increase sequentially and a 2.6% increase year-over-year.
• Clear Aligner revenues were $831.7 million, up 1.8% sequentially but down 0.1% year-over-year, while Clear Aligner volume increased 6.2% sequentially and 3.2% year-over-year.
• Imaging Systems and CAD/CAM Services revenues were $196.8 million, showing a strong 9.2% sequential increase and a 16.1% year-over-year increase.
• The company's GAAP diluted net income per share was $1.28, and non-GAAP diluted net income per share was $2.41.
• Foreign exchange had an unfavorable impact on total revenues by approximately $11.6 million sequentially and $18.1 million year-over-year.
• Operating income was $147.0 million, with a GAAP operating margin of 14.3%, while non-GAAP operating margin was 22.3%.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to solid revenue growth and strong performance in imaging systems, but tempered by concerns about declining clear aligner ASPs, foreign exchange impacts, and a slight decrease in net income. The delay in the iTero Lumina launch is also a negative factor.

Positives

• Total Invisalign patients have surpassed 18 million globally, indicating strong market adoption.
• Imaging Systems and CAD/CAM Services revenues showed robust growth, suggesting strong demand for their scanner technology.
• Clear Aligner volume increased both sequentially and year-over-year, driven by growth in both adult and teen cases.
• Non-GAAP operating margin improved both sequentially and year-over-year, demonstrating improved profitability.
• The company has a strong cash position with over $782.1 million in cash, cash equivalents, and marketable securities.
• The company has $500 million remaining available for share repurchases.

Negatives

• Clear Aligner revenues decreased slightly year-over-year, indicating some challenges in this segment.
• Foreign exchange had a significant negative impact on revenues and operating margins.
• GAAP operating margin decreased both sequentially and year-over-year.
• Clear Aligner ASPs were down sequentially and lower than anticipated due to foreign exchange, discounts, and product mix.
• Net income and diluted EPS decreased compared to the same quarter last year.

Risks

• Unfavorable foreign exchange rates continue to negatively impact revenue and profitability.
• The company faces competition from existing and new competitors in the clear aligner and digital dentistry markets.
• Macroeconomic conditions, including inflation and potential recessions, could impact consumer spending and demand for Align's products.
• The company's future performance is subject to risks related to product development, regulatory approvals, and supply chain disruptions.
• The company's Q3 outlook anticipates a sequential decrease in Clear Aligner volume and ASPs due to seasonality and foreign exchange.

Future Outlook

The company expects Q3 2024 worldwide revenues to be in the range of $980 million to $1,000 million, with a sequential decrease in Clear Aligner volume and ASPs. Full year 2024 total revenue growth is expected to be up 4% to 6% year-over-year. The commercial launch of the iTero Lumina with restorative capabilities is now expected in Q1 2025.

Management Comments

• Align Technology President and CEO Joe Hogan stated that he was pleased to report solid second quarter results.
• Joe Hogan noted that Q2 2024 revenues reflected growth in both Clear Aligner volumes and Imaging Systems and CAD/CAM Services revenues.
• Joe Hogan mentioned that Clear Aligner ASPs were lower than anticipated due to foreign exchange, discounts, and product mix.
• Joe Hogan highlighted the strong teen case starts across the regions, led by strength in the Asia Pacific, EEMA, and Latin America regions.
• Joe Hogan noted that adult patient case starts were up 5.0% sequentially and 1.0% year-over-year, reflecting the highest number of adult shipments in 8 quarters.

Industry Context

The results reflect the ongoing growth in the digital dentistry market, with Align's scanner technology and clear aligner systems continuing to gain traction. The company's performance is also influenced by global economic conditions and currency fluctuations, which impact the broader medical device industry.

Comparison to Industry Standards

• Align's growth in imaging systems and CAD/CAM services is comparable to other companies in the digital dentistry space, such as Dentsply Sirona, which also reports growth in its digital solutions segment.
• The sequential growth in clear aligner volume is a positive sign, but the slight year-over-year decline in clear aligner revenue indicates that Align is facing pricing pressures, similar to what other clear aligner companies like SmileDirectClub have experienced.
• Align's non-GAAP operating margin of 22.3% is relatively strong compared to some of its competitors in the medical device industry, but it is important to note that this is a non-GAAP metric and may not be directly comparable to other companies' reported results.
• The company's investment in Heartland Dental is a strategic move to expand its reach within the dental service organization (DSO) market, which is a growing trend in the dental industry.

Management Changes

Legal Proceedings

• The company agreed in principle to settle legal matters for a total of $31.1 million, primarily related to the Misty Snow Antitrust Class Action.

Stakeholder Impact

• Shareholders may experience some volatility in the stock price due to the mixed financial results and revised outlook.
• Employees may be impacted by the organizational changes and the company's focus on efficiency.
• Customers will benefit from the continued innovation and expansion of Align's product offerings.
• Suppliers may be affected by changes in the company's manufacturing and supply chain strategies.

Next Steps

• The company will host a conference call to review the second quarter results and discuss future operating trends.
• Align will continue to focus on expanding its market reach and product offerings.
• The company will seek court or administrative approvals for the settlement of legal matters in the second half of fiscal year 2024.
• Align will continue to invest in capital expenditures to support continued expansion.

Key Dates

Keywords

Invisalign, Clear Aligners, iTero, Digital Dentistry, CAD/CAM, Orthodontics, Medical Devices, Revenue, Operating Margin, Financial Results